Company news
Anhui Golden Seed Winery Co., Ltd. Class A (SSE:600199) news
Anhui Golden Seed Winery Co., Ltd. Class A news releases on 6ix. Latest, Sep 29, 2026: (600199)"Anhui Golden Seed Winery Co., Ltd."Announcement on Resolutions…
Press releases & updates
(600199)"Anhui Golden Seed Winery Co., Ltd."Announcement on Resolutions of the 1st Meeting of the 8th Board of Directors
September 28, 2026
(600199)"Anhui Golden Seed Winery Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
September 28, 2026
(600199)"Anhui Golden Seed Winery Co., Ltd."Announcement on Completion of Election of New Board of Directors and Appointment of Senior Executives and Securities Affairs Representative
September 28, 2026
"Anhui Golden Seed Winery Co., Ltd."Announcement on Appointment of Board Secretary
September 28, 2026
"Anhui Golden Seed Winery Co., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026
September 10, 2026
"Anhui Golden Seed Winery Co., Ltd."Semi-annual Report for 2026
August 28, 2026
"Anhui Golden Seed Winery Co., Ltd."Announcement on Abnormal Fluctuations in Stock Trading
July 30, 2026
"Anhui Golden Seed Winery Co., Ltd."Announcement on Expected Loss in Semi-annual Performance for 2026
July 14, 2026
"Anhui Golden Seed Winery Co., Ltd."Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual Report
July 6, 2026
Announcement on Cancellation of Some Special Accounts for Raised Funds
June 5, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 22, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 15, 2026
Announcement on Provision for Impairment of Reversed Assets
April 28, 2026
Announcement on Appointment of General Manager and Change of Legal Representative
April 1, 2026
Announcement on Change of the Signing Accountant
February 24, 2026
Announcement on Abnormal Fluctuations in Stock Trading
February 2, 2026
Announcement on Expected Loss in Performance for 2025
January 27, 2026
Indicative Announcement on Expected Loss in Performance for 2025
January 11, 2026
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
December 18, 2025
Announcement on Adjusting Construction Content and Postponing Investment Projects Financed by Raised Funds
December 2, 2025
Indicative Announcement on Postponing Election of Board of Directors at Expiry of Term of Office
December 1, 2025
Announcement on Progress in Proposed Transfer of a 92% Equity Stake in the Holding Subsidiary Goldsun Pharmaceutical via Public Listing
November 7, 2025
Report for Q3 2025
October 29, 2025
Announcement on Change of Chief Financial Officer
September 10, 2025
Announcement on Resolutions of the 16th Meeting of the 7th Board of Directors
August 27, 2025
Announcement on Change of Sponsor Representative for Continuous Supervision
July 15, 2025
Announcement on Expected Decrease in Semi-annual Performance for 2025
July 14, 2025
Announcement on Resignation of Directors and General Manager
July 2, 2025
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025
June 26, 2025
Clarification Announcement on Media Coverage
June 19, 2025
Announcement on Changing Business Scope and Amending the Articles of Association
June 10, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
May 29, 2025
Announcement on Adjusting the Strategy Committee of the Board of Directors to the Strategy and ESG Committee of the Board of Directors and Amending Relevant Policies
April 28, 2025
Indicative Announcement on Obtaining Approval from Fuyang State-owned Assets Supervision and Administration Commission for Transferring Equity of Holding Subsidiary
April 23, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
February 13, 2025
Announcement on Expected Loss in Annual Performance for 2024
January 16, 2025
Announcement on the Board of Directors' Approval of the Proposal by the Board of Supervisors to Convene the Extraordinary General Meeting
January 13, 2025
Announcement on Retirement and Resignation of Senior Executives of the Company
November 28, 2024
Announcement on Changing Signatory Certified Public Accountant
October 31, 2024
Announcement on Main Operating Data in Q3 2024
October 25, 2024
Announcement on Convening Q3 2024 Performance Briefing
October 21, 2024
Announcement on Adjusting the Members of Special Committees of the 7th Board of Directors
August 27, 2024
Announcement on the Completion of Cancellation of Anhui Golden Sun Biochemical Pharmaceutical Co., Ltd.
August 14, 2024
Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
July 30, 2024
Notice on Convening the 1st Extraordinary General Meeting in 2024
July 12, 2024
Announcement on Expected Gains in Semi-annual Performance for 2024
July 9, 2024
Announcement on Resolutions of 2023 Annual General Meeting
June 7, 2024
Announcement on Retirement and Resignation of Securities Affairs Representative
May 31, 2024
Announcement on Convening Performance Meeting for 2023 and 1st Quarter of 2024
May 17, 2024
Announcement on Completion of Transferring Land Use Right by Company and Related Transaction
April 29, 2024